12 March 2026

Paris-based Waiv, which uses AI to enable more precise testing of cancer, raised $33M after spinning out of AI diagnostics and drug discovery platform Owkin (Martin Coulter/Sifted)

Martin Coulter / Sifted:
Paris-based Waiv, which uses AI to enable more precise testing of cancer, raised $33M after spinning out of AI diagnostics and drug discovery platform Owkin  —  French healthtech aims to revolutionise cancer screening  —  Waiv, a Paris-based medical testing startup spun out of biotech unicorn Owkin …

Posted from: this blog via Microsoft Power Automate.

Daily Deals